• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于纳米结构脂质载体的水凝胶药物递送制剂:综述

Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a comprehensive review.

作者信息

Doktorovova Slavomira, Souto Eliana B

机构信息

Faculty of Health Sciences, Fernando Pessoa University, Rua Carlos da Maia 296, 4200-15o Porto, Portugal.

出版信息

Expert Opin Drug Deliv. 2009 Feb;6(2):165-76. doi: 10.1517/17425240802712590.

DOI:10.1517/17425240802712590
PMID:19239388
Abstract

The scientific literature today provides several systems that can deliver active pharmaceutical ingredients (APIs) across the skin. These include reservoir matrices, matrix diffusion-controlled devices, multiple polymer devices and multilayer matrix assemblies. Among these, nanostructured lipid carriers (NLC) have emerged as novel systems composed of physiological lipid materials suitable for topical, dermal and transdermal administration. This review focuses on the design characteristics, production and composition of semi-solid formulations containing NLC as API carriers. One of the useful semi-solid systems are hydrogels, which can be used as vehicles to provide appropriate consistency for NLC formulations to be applied onto the skin. In the present review recent developments in the field are highlighted, including examples of APIs successfully entrapped within NLC now amenable for delivery via the skin. Further innovations in NLC composition and formulation, as well as in semi-solid hydrogel assemblies, are likely to expand the number of APIs available for topical, dermal and transdermal delivery.

摘要

如今的科学文献提供了多种可透过皮肤递送活性药物成分(API)的系统。这些系统包括储库型基质、基质扩散控制型装置、多重聚合物装置和多层基质组件。其中,纳米结构脂质载体(NLC)已成为由适合局部、真皮和透皮给药的生理性脂质材料组成的新型系统。本综述聚焦于以NLC作为API载体的半固体制剂的设计特点、生产及组成。水凝胶是一种有用的半固体系统,可作为载体为应用于皮肤的NLC制剂提供适宜的稠度。在本综述中突出了该领域的最新进展,包括成功包封于NLC内、现可经皮肤递送的API实例。NLC组成和制剂以及半固体水凝胶组件方面的进一步创新,可能会增加可用于局部、真皮和透皮递送的API数量。

相似文献

1
Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a comprehensive review.基于纳米结构脂质载体的水凝胶药物递送制剂:综述
Expert Opin Drug Deliv. 2009 Feb;6(2):165-76. doi: 10.1517/17425240802712590.
2
Nanostructuring lipid carriers using Ridolfia segetum (L.) Moris essential oil.利用瑞多福瑞达(L.)莫里斯精油进行纳米结构脂质载体。
Mater Sci Eng C Mater Biol Appl. 2019 Oct;103:109804. doi: 10.1016/j.msec.2019.109804. Epub 2019 May 30.
3
Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity.载咪康唑的纳米结构化脂质载体(NLC)用于口腔黏膜局部递药:提高抗真菌活性。
Colloids Surf B Biointerfaces. 2013 Nov 1;111:755-63. doi: 10.1016/j.colsurfb.2013.05.041. Epub 2013 Jul 4.
4
Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations.评估脂质体纳米粒(SLN)和纳米结构脂质载体(NLC)在纳入水凝胶制剂前后的物理稳定性。
Eur J Pharm Biopharm. 2004 Jul;58(1):83-90. doi: 10.1016/j.ejpb.2004.02.015.
5
QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment.基于质量源于设计的早期药物研发研究:高压均质法生产用于皮肤癌治疗的脂质纳米粒。
Int J Pharm. 2019 May 30;563:110-121. doi: 10.1016/j.ijpharm.2019.03.056. Epub 2019 Mar 29.
6
Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.采用共包封纳米结构脂质载体的经皮传递的被动和主动策略:体外与体内研究。
Eur J Pharm Biopharm. 2014 Feb;86(2):133-44. doi: 10.1016/j.ejpb.2013.12.004. Epub 2013 Dec 11.
7
Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.基于固体脂质纳米粒(SLN)和纳米结构脂质载体(NLC)的经皮给药制剂:综述。
Eur J Pharm Sci. 2018 Jan 15;112:159-167. doi: 10.1016/j.ejps.2017.11.023. Epub 2017 Nov 26.
8
Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations.载有米诺地尔的纳米结构脂质载体(NLC):局部用制剂的表征及流变行为
Pharmazie. 2009 Mar;64(3):177-82.
9
Nanostructured lipid carriers for transdermal delivery of acid labile lansoprazole.用于酸不稳定型兰索拉唑经皮递送的纳米结构脂质载体。
Eur J Pharm Biopharm. 2016 Nov;108:297-303. doi: 10.1016/j.ejpb.2016.07.015. Epub 2016 Jul 20.
10
Physicochemical characterization and in vitro release studies of ascorbyl palmitate-loaded semi-solid nanostructured lipid carriers (NLC gels).负载棕榈酸维生素C的半固体纳米结构脂质载体(NLC凝胶)的物理化学表征及体外释放研究
J Microencapsul. 2008 Mar;25(2):111-20. doi: 10.1080/02652040701817762.

引用本文的文献

1
Nanomedicine-Based Ophthalmic Drug Delivery Systems for the Treatment of Ocular Diseases.用于治疗眼部疾病的基于纳米医学的眼科药物递送系统
Int J Nanomedicine. 2025 Jul 21;20:9221-9249. doi: 10.2147/IJN.S532074. eCollection 2025.
2
Enhanced therapeutic effects of all-trans retinoic acid nanostructured lipid carrier composite gel drug delivery system for alopecia areata.全反式维甲酸纳米结构脂质载体复合凝胶给药系统对斑秃的增强治疗效果。
J Nanobiotechnology. 2025 May 16;23(1):351. doi: 10.1186/s12951-025-03407-w.
3
Emerging nano-derived therapy for the treatment of dementia: a comprehensive review.
新兴的纳米衍生疗法治疗痴呆症:综述
Drug Deliv Transl Res. 2025 Apr 23. doi: 10.1007/s13346-025-01863-3.
4
Targeting Acne: Development of Monensin-Loaded Nanostructured Lipid Carriers.靶向治疗痤疮:载莫能菌素纳米结构脂质载体的研发
Int J Nanomedicine. 2025 Feb 19;20:2181-2204. doi: 10.2147/IJN.S497108. eCollection 2025.
5
A Novel Strategy for Topical Administration by Combining Chitosan Hydrogel Beads with Nanostructured Lipid Carriers: Preparation, Characterization, and Evaluation.壳聚糖水凝胶珠与纳米结构脂质载体结合用于局部给药的新策略:制备、表征与评价
Gels. 2024 Feb 21;10(3):160. doi: 10.3390/gels10030160.
6
Lipid Nano-System Based Topical Drug Delivery for Management of Rheumatoid Arthritis: An Overview.基于脂质纳米系统的类风湿关节炎局部给药治疗:综述
Adv Pharm Bull. 2023 Nov;13(4):663-677. doi: 10.34172/apb.2023.075. Epub 2023 Apr 29.
7
Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review.固体脂质纳米粒与纳米结构脂质载体:比较综述
Pharmaceutics. 2023 May 25;15(6):1593. doi: 10.3390/pharmaceutics15061593.
8
A Novel Topical Formulation of the Leishmaniasis Drug Glucantime as a Nanostructured Lipid Carrier-Based Hydrogel.一种新型利什曼病药物葡萄糖胺的局部制剂,作为基于纳米结构脂质载体的水凝胶。
Am J Trop Med Hyg. 2023 Jun 12;109(2):301-314. doi: 10.4269/ajtmh.23-0116. Print 2023 Aug 2.
9
Encapsulated Oxovanadium(IV) and Dioxovanadium(V) Complexes into Solid Lipid Nanoparticles Increase Cytotoxicity Against MDA-MB-231 Cell Line.将包裹氧钒(IV)和二氧钒(V)的配合物装入固体脂质纳米粒可提高对 MDA-MB-231 细胞系的细胞毒性。
Int J Nanomedicine. 2023 May 11;18:2507-2523. doi: 10.2147/IJN.S403689. eCollection 2023.
10
Wound Healing Efficacy of Rosuvastatin Transethosomal Gel, I Optimal Optimization, Histological and In Vivo Evaluation.瑞舒伐他汀转质体凝胶的伤口愈合功效,I. 优化、组织学及体内评估
Pharmaceutics. 2022 Nov 19;14(11):2521. doi: 10.3390/pharmaceutics14112521.